Inhibition of RIP1 improves immune reconstitution and reduces GVHD mortality while preserving graft-versus-leukemia effects
Mariano Prado Acosta(Icahn School of Medicine at Mount Sinai), James L.M. Ferrara(Tisch Hospital)
Cited by 18
Related Papers
Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation
|Biology of Blood and Marrow Transplantation|2005|458
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD
|Journal of Clinical Oncology|2021|247
Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease
|Journal of Clinical Investigation|2018|135